Financial News
All News about Hemogenyx Pharmaceuticals Plc.
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 26, 2024
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson
September 08, 2024
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
September 01, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Brain Delivery
February 15, 2024
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Intranasal Delivery
February 13, 2024
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Final Results
April 24, 2024
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
March 27, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise US$4.2 million
February 28, 2024
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375
November 28, 2023
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - Clinical Hold Lift Plan is accepted by FDA
September 14, 2023
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Patent Application Update
September 08, 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.